Byzantium Trust is an international venture capital and private equity buy-out firm with offices in Toronto, Andorra, Grand Cayman, and London, UK.
Byzantium Trust was formed by a successful group of entrepreneurs with the principal goal of acquiring and growing undervalued businesses. Our equity base is provided entirely by our principals and private limited partners with investments ranging from €500,000 to €15,000,000 and leveraged buyouts of companies up to €200mm in sales.
Private Equity
Byzantium Trust looks to purchase controlling interests in stable, profitable businesses in the pharmaceuticals and consumer health markets. We focus on defensible and stable products and services that address large existing markets that require strategic promotion or realignment.
We are equally interested in:
- Divisional or corporate divestitures
- Management buy-outs
- Fragmented industry consolidations
- Byzantium Trust seeks management teams with successful track records and domain expertise where contribution of capital, structuring experience and contacts we provide can together maximize shareholder value.
Venture Capital
Byzantium Trust’s objective is to build high value life sciences and emerging technology companies that provide consistently superior returns to both investors and entrepreneurs. To achieve this goal, we identify, research, fund, and actively support entrepreneurial endeavors that we believe have the best chance for success in today’s intensely competitive world.
We sustain our business model by:
- Focusing our investments on real technologies with discernible promise
- Leveraging the strength of our team’s operational backgrounds to actively foster our portfolio companies’ success using a hands-on approach
- Connecting our entrepreneurs with an extensive network of partners and resources garnered over many years
- Consistently delivering solid returns to our partners and entrepreneurs
